Bob Iger’s fast start back as Disney’s CEO is welcome news to shareholders like us

Bob Iger’s fast start back as Disney’s CEO is welcome news to shareholders like us


Bob Iger, former CEO, The Walt Disney Company

Scott Mlyn | CNBC

Bob Iger, who returned last week as CEO of Disney (DIS), told employees Monday he intends to maintain the company’s current hiring freeze. He also reiterated the need for Disney to pivot its streaming business objective away from subscriber growth at all costs and toward profitability. As shareholders for the Club, we are pleased to see Iger taking steps to fix the missteps of his predecessor.



Source

The price of menstrual products is skyrocketing from inflation, tariffs
Business

The price of menstrual products is skyrocketing from inflation, tariffs

Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024.  Dado Ruvic | Reuters Rising inflation and ever-changing tariff policies have led to higher prices across store shelves over the past few years, squeezing consumers’ budgets. An often overlooked example: menstrual products. The average price of menstrual […]

Read More
Nissan’s new hybrid is a U.S.-first that mixes EV driving with a gas engine
Business

Nissan’s new hybrid is a U.S.-first that mixes EV driving with a gas engine

Nissan’s logo is illuminated on a prototype of its new all-electric Ariya crossover. Nissan’s Z Proto performance car is reflected in the vehicle’s grille, while a redesigned Nissan Pathfinder SUV sits in the background. Michael Wayland / CNBC Nissan Motor plans to introduce a new type of hybrid to the U.S. market that drives like […]

Read More
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
Business

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized combo on Dec. 8, 2025 in New York City. Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are now popular for weight loss, according to a […]

Read More